Status:
RECRUITING
Stuttering and Neuromodulation
Lead Sponsor:
NYU Langone Health
Conditions:
Stuttering
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of this study is to collect preliminary data on the efficacy of transcranial direct current stimulation (tDCS) combined with traditional behavioral techniques to reduce stuttering severity...
Eligibility Criteria
Inclusion
- Adults aged 18 to 65 years.
- Diagnosis of developmental stuttering, verified by a licensed speech-language pathologist.
- Mild-to-moderate or greater stuttering severity, defined as a score of 20 or higher on the Stuttering Severity Instrument-Fourth Edition (SSI-4).
- English as a primary language.
- Right-handedness (to minimize variability in neural lateralization).
- Willing and able to attend all study sessions and follow study procedures.
Exclusion
- Have a history of neurological, psychiatric, or medical conditions that are contraindicated for tDCS.
- Are currently taking medications known to affect cortical excitability.
- Have a history of seizures or epilepsy.
- Are pregnant or planning to become pregnant during the study period.
- Have metal implants in the head (excluding dental work) or other contraindications to electrical brain stimulation.
- Any skin disorder or skin sensitive area near stimulation locations.
Key Trial Info
Start Date :
September 4 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2027
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT07222163
Start Date
September 4 2025
End Date
October 1 2027
Last Update
October 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016